Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 588 of 1,261

  1. US 9855347

    Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

    Aura Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  2. US 9855251

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  3. US 9856241

    Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

    Karyopharm Therapeutics Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  4. US 9856310

    UTI fusion proteins

    Takeda Pharmaceutical Company Limited · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  5. US 9856539

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  6. US 9856313

    Epitope of RSV fusion protein and antibody recognizing the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  7. US 9856262

    Analogues of 4H-pyrazolo[1,5-a] benzimidazole compound as PARP inhibitors

    Medshine Discovery Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  8. US 9855291

    Anti-kidney associated antigen 1 (KAAG1) antibodies

    ADC THERAPEUTICS SA · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  9. US 9856204

    Methods for inhibiting muscle atrophy

    THE UNITED STATES OF AMERICA AS REPRESENTED BY VETERANS AFFAIRS · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  10. US 9856475

    Formulations for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  11. US 9856467

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  12. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  13. US 9856468

    Processable single chain molecules and polypeptides made using same

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  14. US 9856283

    Thiosaccharide mucolytic agents

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9856273

    ETP derivatives

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  16. US 9856264

    Isoquinolinesulfonyl derivative as RHO kinase inhibitor

    Medshine Discovery Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  17. US 9856260

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Alliance Discovery, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  18. US 9856248

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  19. US 9856279

    Therapeutically active compositions and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  20. US 9856238

    1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

    PGI Drug Discovery LLC · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  21. US 9856206

    Oligo-benzamide compounds and their use

    The Board of Regents of the University of Texas System · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  22. US 9856231

    Tetrahydrothiophene-based GABA aminotransferase inactivators

    Northwestern University · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  23. US 9855368

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  24. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.